NovoCure Limited
Last updated September 27, 2026
Organization details
- Legal name
- NovoCure Limited
- Ownership
- Public
- Status
- Active
- Headquarters country
- Jersey
- Ticker symbol
- NVCR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001645113
Board of directors
-
Allyson J. Ocean · DirectorSince 2023
-
Asaf Danziger · Director · Chief Executive OfficerSince 2023
-
David Hung · DirectorSince 2023
-
Gabriel Leung · DirectorSince 2023
-
Jeryl L. Hilleman · DirectorSince 2023
-
Kristin Stafford · DirectorSince 2023
-
Martin J. Madden · DirectorSince 2023
-
Timothy J. Scannell · DirectorSince 2023
-
W. Anthony Vernon · DirectorSince 2023
Chief executives
Asaf Danziger
· Chief Executive Officer
Dates unknown
Board connections
5 of this board's directors also sit on 6 other boards.
- via David Hung and W. Anthony Vernon
- via Timothy J. Scannell
- via W. Anthony Vernon
- via Martin J. Madden
- via Jeryl L. Hilleman
- via Jeryl L. Hilleman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 7, 2023 | Shah Pritesh Officer (Chief Growth Officer) | Open-market sale | −382 | $12.65 | $4,832 |
| Nov 2, 2023 | Cordova Ashley Officer (Chief Financial Officer) | Option exercise | +175 | $11.46 | $2,006 |
| Oct 31, 2023 | Puri Michal Nath Officer (Chief Human Resources Officer) | Grant or award | +37,593 | — | — |
| Oct 31, 2023 | Cordova Ashley Officer (Chief Financial Officer) | Option exercise | +7,561 | $11.46 | $86,649 |
| Oct 31, 2023 | Cordova Ashley Officer (Chief Financial Officer) | Option exercise | +2,480 | $11.44 | $28,371 |
| Oct 31, 2023 | Cordova Ashley Officer (Chief Financial Officer) | Option exercise | +7,752 | $7.15 | $55,427 |
| Sep 1, 2023 | Cordova Ashley Officer (Chief Financial Officer) | Open-market sale | −883 | $21.82 | $19,267 |
| Sep 1, 2023 | GROENHUYSEN WILHELMUS CM Officer (Chief Operating Officer) | Open-market sale | −294 | $21.82 | $6,415 |
| Sep 1, 2023 | Shah Pritesh Officer (Chief Growth Officer) | Open-market sale | −273 | $21.82 | $5,957 |
| Aug 2, 2023 | Cordova Ashley Officer (Chief Financial Officer) | Open-market sale | −1,144 | $30.25 | $34,606 |
| Jun 30, 2023 | Weinberg Uri Officer (Chief Innovation Officer) | Grant or award | +305 | $35.28 | $10,760 |
| Jun 30, 2023 | GROENHUYSEN WILHELMUS CM Officer (Chief Operating Officer) | Grant or award | +366 | $35.28 | $12,912 |
| Jun 30, 2023 | Shah Pritesh Officer (Chief Growth Officer) | Grant or award | +367 | $35.28 | $12,948 |
| Jun 30, 2023 | Burke William Patrick Officer (Chief Human Resources Officer) | Grant or award | +357 | $35.28 | $12,595 |
| Jun 30, 2023 | Ben Arye Barak Officer (General Counsel) | Grant or award | +288 | $35.28 | $10,161 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.